JOHNSON & JOHNSON (1JNJ.MI) Fundamental Analysis & Valuation

BIT:1JNJ • US4781601046

Current stock price

211.4 EUR
+5.05 (+2.45%)
Last:

This 1JNJ.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 1JNJ.MI Profitability Analysis

1.1 Basic Checks

  • 1JNJ had positive earnings in the past year.
  • In the past year 1JNJ had a positive cash flow from operations.
  • Each year in the past 5 years 1JNJ has been profitable.
  • In the past 5 years 1JNJ always reported a positive cash flow from operatings.
1JNJ.MI Yearly Net Income VS EBIT VS OCF VS FCF1JNJ.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

1.2 Ratios

  • 1JNJ's Return On Assets of 13.46% is amongst the best of the industry. 1JNJ outperforms 85.19% of its industry peers.
  • 1JNJ has a Return On Equity of 32.87%. This is in the better half of the industry: 1JNJ outperforms 75.93% of its industry peers.
  • 1JNJ's Return On Invested Capital of 14.37% is fine compared to the rest of the industry. 1JNJ outperforms 68.52% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1JNJ is in line with the industry average of 14.90%.
Industry RankSector Rank
ROA 13.46%
ROE 32.87%
ROIC 14.37%
ROA(3y)14.08%
ROA(5y)12.66%
ROE(3y)34.55%
ROE(5y)31.04%
ROIC(3y)16.34%
ROIC(5y)15%
1JNJ.MI Yearly ROA, ROE, ROIC1JNJ.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • With an excellent Profit Margin value of 28.46%, 1JNJ belongs to the best of the industry, outperforming 90.74% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1JNJ has grown nicely.
  • With a decent Operating Margin value of 27.78%, 1JNJ is doing good in the industry, outperforming 70.37% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1JNJ has grown nicely.
  • The Gross Margin of 1JNJ (67.92%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of 1JNJ has remained more or less at the same level.
Industry RankSector Rank
OM 27.78%
PM (TTM) 28.46%
GM 67.92%
OM growth 3Y6.15%
OM growth 5Y6.99%
PM growth 3Y8.26%
PM growth 5Y9.82%
GM growth 3Y-0.67%
GM growth 5Y0.65%
1JNJ.MI Yearly Profit, Operating, Gross Margins1JNJ.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. 1JNJ.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1JNJ is still creating some value.
  • 1JNJ has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, 1JNJ has less shares outstanding
  • 1JNJ has a worse debt/assets ratio than last year.
1JNJ.MI Yearly Shares Outstanding1JNJ.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
1JNJ.MI Yearly Total Debt VS Total Assets1JNJ.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • An Altman-Z score of 5.12 indicates that 1JNJ is not in any danger for bankruptcy at the moment.
  • 1JNJ's Altman-Z score of 5.12 is fine compared to the rest of the industry. 1JNJ outperforms 75.93% of its industry peers.
  • The Debt to FCF ratio of 1JNJ is 2.43, which is a good value as it means it would take 1JNJ, 2.43 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 2.43, 1JNJ is doing good in the industry, outperforming 74.07% of the companies in the same industry.
  • A Debt/Equity ratio of 0.56 indicates that 1JNJ is somewhat dependend on debt financing.
  • 1JNJ has a Debt to Equity ratio (0.56) which is in line with its industry peers.
  • Even though the debt/equity ratio score it not favorable for 1JNJ, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.43
Altman-Z 5.12
ROIC/WACC1.49
WACC9.67%
1JNJ.MI Yearly LT Debt VS Equity VS FCF1JNJ.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.3 Liquidity

  • A Current Ratio of 1.03 indicates that 1JNJ should not have too much problems paying its short term obligations.
  • 1JNJ has a Current ratio of 1.03. This is in the lower half of the industry: 1JNJ underperforms 77.78% of its industry peers.
  • 1JNJ has a Quick Ratio of 1.03. This is a bad value and indicates that 1JNJ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1JNJ has a worse Quick ratio (0.77) than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.77
1JNJ.MI Yearly Current Assets VS Current Liabilites1JNJ.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 1JNJ.MI Growth Analysis

3.1 Past

  • 1JNJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.11%, which is quite good.
  • 1JNJ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.11% yearly.
  • Looking at the last year, 1JNJ shows a small growth in Revenue. The Revenue has grown by 6.05% in the last year.
  • The Revenue has been growing slightly by 2.67% on average over the past years.
EPS 1Y (TTM)8.11%
EPS 3Y2.06%
EPS 5Y6.11%
EPS Q2Q%20.59%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y5.6%
Revenue growth 5Y2.67%
Sales Q2Q%9.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.75% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y7.88%
EPS Next 2Y8.2%
EPS Next 3Y8.39%
EPS Next 5Y8.75%
Revenue Next Year7.21%
Revenue Next 2Y6.4%
Revenue Next 3Y6.15%
Revenue Next 5Y6.02%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1JNJ.MI Yearly Revenue VS Estimates1JNJ.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
1JNJ.MI Yearly EPS VS Estimates1JNJ.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

2

4. 1JNJ.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 22.61, 1JNJ is valued on the expensive side.
  • The rest of the industry has a similar Price/Earnings ratio as 1JNJ.
  • When comparing the Price/Earnings ratio of 1JNJ to the average of the S&P500 Index (25.79), we can say 1JNJ is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 20.95, 1JNJ is valued on the expensive side.
  • The rest of the industry has a similar Price/Forward Earnings ratio as 1JNJ.
  • 1JNJ's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.80.
Industry RankSector Rank
PE 22.61
Fwd PE 20.95
1JNJ.MI Price Earnings VS Forward Price Earnings1JNJ.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1JNJ.
  • 1JNJ's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 29.86
EV/EBITDA 17.9
1JNJ.MI Per share data1JNJ.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1JNJ does not grow enough to justify the current Price/Earnings ratio.
  • 1JNJ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.87
PEG (5Y)3.7
EPS Next 2Y8.2%
EPS Next 3Y8.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. 1JNJ.MI Dividend Analysis

5.1 Amount

  • 1JNJ has a Yearly Dividend Yield of 2.15%.
  • Compared to an average industry Dividend Yield of 1.92, 1JNJ pays a bit more dividend than its industry peers.
  • 1JNJ's Dividend Yield is comparable with the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 2.15%

5.2 History

  • On average, the dividend of 1JNJ grows each year by 7.68%, which is quite nice.
Dividend Growth(5Y)7.68%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 46.19% of the earnings are spent on dividend by 1JNJ. This is a bit on the high side, but may be sustainable.
  • The dividend of 1JNJ is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP46.19%
EPS Next 2Y8.2%
EPS Next 3Y8.39%
1JNJ.MI Yearly Income VS Free CF VS Dividend1JNJ.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B
1JNJ.MI Dividend Payout.1JNJ.MI Dividend Payout, showing the Payout Ratio.1JNJ.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1JNJ.MI Fundamentals: All Metrics, Ratios and Statistics

JOHNSON & JOHNSON

BIT:1JNJ (3/16/2026, 7:00:00 PM)

211.4

+5.05 (+2.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-21
Earnings (Next)04-14
Inst Owners75.62%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap509.45B
Revenue(TTM)94.19B
Net Income(TTM)26.80B
Analysts75.63
Price Target197.11 (-6.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.15%
Yearly Dividend4.48
Dividend Growth(5Y)7.68%
DP46.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.21%
Min EPS beat(2)-0.13%
Max EPS beat(2)0.55%
EPS beat(4)3
Avg EPS beat(4)2.17%
Min EPS beat(4)-0.13%
Max EPS beat(4)5.96%
EPS beat(8)7
Avg EPS beat(8)2.84%
EPS beat(12)10
Avg EPS beat(12)3.23%
EPS beat(16)14
Avg EPS beat(16)3.09%
Revenue beat(2)2
Avg Revenue beat(2)0.35%
Min Revenue beat(2)0.03%
Max Revenue beat(2)0.67%
Revenue beat(4)4
Avg Revenue beat(4)1.04%
Min Revenue beat(4)0.03%
Max Revenue beat(4)2.92%
Revenue beat(8)5
Avg Revenue beat(8)0.32%
Revenue beat(12)8
Avg Revenue beat(12)-0.5%
Revenue beat(16)8
Avg Revenue beat(16)-4.44%
PT rev (1m)-0.08%
PT rev (3m)10.97%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)-3.28%
EPS NY rev (1m)0%
EPS NY rev (3m)0.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.86%
Valuation
Industry RankSector Rank
PE 22.61
Fwd PE 20.95
P/S 6.24
P/FCF 29.86
P/OCF 23.98
P/B 7.21
P/tB N/A
EV/EBITDA 17.9
EPS(TTM)9.35
EY4.42%
EPS(NY)10.09
Fwd EY4.77%
FCF(TTM)7.08
FCFY3.35%
OCF(TTM)8.82
OCFY4.17%
SpS33.86
BVpS29.31
TBVpS-6.34
PEG (NY)2.87
PEG (5Y)3.7
Graham Number78.53
Profitability
Industry RankSector Rank
ROA 13.46%
ROE 32.87%
ROCE 18.03%
ROIC 14.37%
ROICexc 16.57%
ROICexgc 67.45%
OM 27.78%
PM (TTM) 28.46%
GM 67.92%
FCFM 20.91%
ROA(3y)14.08%
ROA(5y)12.66%
ROE(3y)34.55%
ROE(5y)31.04%
ROIC(3y)16.34%
ROIC(5y)15%
ROICexc(3y)19.6%
ROICexc(5y)18.23%
ROICexgc(3y)74.51%
ROICexgc(5y)73.44%
ROCE(3y)20.24%
ROCE(5y)18.7%
ROICexgc growth 3Y3.9%
ROICexgc growth 5Y-2.01%
ROICexc growth 3Y8.52%
ROICexc growth 5Y5.62%
OM growth 3Y6.15%
OM growth 5Y6.99%
PM growth 3Y8.26%
PM growth 5Y9.82%
GM growth 3Y-0.67%
GM growth 5Y0.65%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.43
Debt/EBITDA 1.36
Cap/Depr 64.4%
Cap/Sales 5.13%
Interest Coverage 6.81
Cash Conversion 72.86%
Profit Quality 73.49%
Current Ratio 1.03
Quick Ratio 0.77
Altman-Z 5.12
F-Score4
WACC9.67%
ROIC/WACC1.49
Cap/Depr(3y)61.79%
Cap/Depr(5y)58.46%
Cap/Sales(3y)5.15%
Cap/Sales(5y)5.02%
Profit Quality(3y)88.82%
Profit Quality(5y)91.38%
High Growth Momentum
Growth
EPS 1Y (TTM)8.11%
EPS 3Y2.06%
EPS 5Y6.11%
EPS Q2Q%20.59%
EPS Next Y7.88%
EPS Next 2Y8.2%
EPS Next 3Y8.39%
EPS Next 5Y8.75%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y5.6%
Revenue growth 5Y2.67%
Sales Q2Q%9.08%
Revenue Next Year7.21%
Revenue Next 2Y6.4%
Revenue Next 3Y6.15%
Revenue Next 5Y6.02%
EBIT growth 1Y12.82%
EBIT growth 3Y12.1%
EBIT growth 5Y9.84%
EBIT Next Year23.18%
EBIT Next 3Y11.51%
EBIT Next 5Y8.55%
FCF growth 1Y-0.73%
FCF growth 3Y4.65%
FCF growth 5Y-0.49%
OCF growth 1Y1.09%
OCF growth 3Y4.99%
OCF growth 5Y0.83%

JOHNSON & JOHNSON / 1JNJ.MI Fundamental Analysis FAQ

What is the fundamental rating for 1JNJ stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1JNJ.MI.


What is the valuation status of JOHNSON & JOHNSON (1JNJ.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to JOHNSON & JOHNSON (1JNJ.MI). This can be considered as Overvalued.


Can you provide the profitability details for JOHNSON & JOHNSON?

JOHNSON & JOHNSON (1JNJ.MI) has a profitability rating of 7 / 10.


What is the valuation of JOHNSON & JOHNSON based on its PE and PB ratios?

The Price/Earnings (PE) ratio for JOHNSON & JOHNSON (1JNJ.MI) is 22.61 and the Price/Book (PB) ratio is 7.21.


What is the financial health of JOHNSON & JOHNSON (1JNJ.MI) stock?

The financial health rating of JOHNSON & JOHNSON (1JNJ.MI) is 5 / 10.